FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

Optimization of Heart Failure Treatment and Implementation of a Risk-based Patient Care Model.

Role: lead

ePro Diary - HDV ( MACROLIVER )

Role: lead

Italian Angelman Syndrome Registry

Role: lead

Transitional ePRO Diary Liver (Transitional-ePRO)

Role: lead

"Referral Attivo" Delta, Dallo Screening Alla Presa in Carico.

Role: lead

A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes

Role: lead

LOW-PV Continuation

Role: lead

Clinical Epidemiology in Contemporary Patients With Myelofibrosis.

Role: lead

Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)

Role: lead

Myeloproliferative Neoplasms (MPN) and COVID-19

Role: lead

Clonal Hematopoiesis of Indeterminate Potential in Heart Failure.

Role: lead

Gait Characteristics and Cognitive Evolution in Parkinson Disease

Role: lead

The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV

Role: lead

Post-COVID-19 Sequelae: Osteonecrosis of Femoral Head

Role: lead

Cuffed Versus Uncuffed Tracheal Tubes in PICU (PICU-BG-TT Study)

Role: lead

ADHerence of ticagrelOr in Real World Patients With aCute Coronary Syndrome

Role: lead

European Registry for Myeloproliferative Neoplasms (MPNs) - Update of ERNEST Study

Role: lead

A Prospective Outcome Study in Patients With Moderate to Severe Traumatic Brain Injury

Role: lead

Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms

Role: lead

Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)

Role: lead